- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting MCL-1 in cancer: current status and perspectives
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-21
DOI
10.1186/s13045-021-01079-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment
- (2021) Maojun Zhou et al. Aging-US
- FGFR-TKI resistance in cancer: current status and perspectives
- (2021) Sitong Yue et al. Journal of Hematology & Oncology
- Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer
- (2020) TAKAYUKI NAKANO et al. ANTICANCER RESEARCH
- Targeting MCL-1 in hematologic malignancies: Rationale and progress
- (2020) AndrewH. Wei et al. BLOOD REVIEWS
- AMG-176, an Mcl-1 antagonist, shows preclinical efficacy in chronic lymphocytic leukemia
- (2020) Xue Yi et al. CLINICAL CANCER RESEARCH
- Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins
- (2020) Karson J. Kump et al. JOURNAL OF MEDICINAL CHEMISTRY
- Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma
- (2020) Thomas J. Ow et al. LARYNGOSCOPE
- Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer
- (2020) Natalie Yan Li Ngoi et al. Cancers
- Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells
- (2020) Chisato Inoue et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pro-apoptotic carboxamide analogues of natural fislatifolic acid targeting Mcl-1 and Bcl-2
- (2020) Shelly Gapil Tiamas et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors
- (2020) Jintong Du et al. Future Medicinal Chemistry
- BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
- (2020) Magdalena Klanova et al. Cancers
- Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
- (2020) Simona D’Aguanno et al. Cells
- Targeting the synthetic vulnerability of PTEN-deficient glioblastoma cells with MCL1 inhibitors
- (2020) Chao Chen et al. MOLECULAR CANCER THERAPEUTICS
- MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
- (2020) Nabanita Mukherjee et al. Cell Death & Disease
- Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
- (2020) Nabanita Mukherjee et al. Cancers
- Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
- (2020) Donia M. Moujalled et al. Blood Advances
- Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
- (2020) Nir Shahar et al. DRUG RESISTANCE UPDATES
- Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent
- (2020) Xing Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of a Potent and Specific FGFR4 Inhibitor for the Treatment of Hepatocellular Carcinoma
- (2020) Renata Rezende Miranda et al. JOURNAL OF MEDICINAL CHEMISTRY
- MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically
- (2020) Enkhtsetseg Munkhbaatar et al. Nature Communications
- Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
- (2020) Caroline Molinaro et al. Cancers
- Interdiction at a protein-protein interface: MCL-1 inhibitors for oncology
- (2020) Kexue Li BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- MCL-1 or BCL-xL-dependent resistance to the BCL-2 antagonist (ABT-199) can be overcome by specific inhibitor as single agents and in combination with ABT-199 in acute myeloid leukemia cells
- (2019) Qing Wang et al. LEUKEMIA & LYMPHOMA
- Recent advances in the development of Mcl-1 inhibitors for cancer therapy
- (2019) Alexander W. Hird et al. PHARMACOLOGY & THERAPEUTICS
- The Coming Decade of Cell Death Research: Five Riddles
- (2019) Douglas R. Green CELL
- Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
- (2019) Taekyu Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- From Inhibition to Degradation: Targeting the Anti-apoptotic Protein Myeloid Cell Leukemia 1 (MCL1)
- (2019) James William Papatzimas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy
- (2019) Viacheslav V. Senichkin et al. TRENDS IN CELL BIOLOGY
- IL-22 Accelerates Thymus Regeneration via Stat3/Mcl-1 and Decreases Chronic Graft-versus-Host Disease in Mice after Allotransplants
- (2019) Bin Pan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models
- (2019) Xing Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity
- (2019) Zoltan Szlávik et al. JOURNAL OF MEDICINAL CHEMISTRY
- MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis
- (2019) Solmaz Shirjang et al. FREE RADICAL BIOLOGY AND MEDICINE
- MIM1 induces COLO829 melanoma cell death through mitochondrial membrane breakdown, GSH depletion, and DNA damage
- (2019) Michalina Respondek et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
- (2019) Chung-Hang Leung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands
- (2019) Ziqian Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes
- (2019) Michalina Respondek et al. PATHOLOGY & ONCOLOGY RESEARCH
- Mcl-1 Interacts with Akt to Promote Lung Cancer Progression
- (2019) Guo Chen et al. CANCER RESEARCH
- Hot-Spots of Mcl-1 Protein
- (2019) Camille Denis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma
- (2019) Michael A. Dengler et al. ONCOGENE
- AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia
- (2019) Hyllana C.D. Medeiros et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML
- (2019) Larissa Ewald et al. Cell Death & Disease
- Upregulation of Mcl-1 inhibits JQ1-triggered anticancer activity in hepatocellular carcinoma cells
- (2018) Hua-Peng Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Noxa: Role in Cancer Pathogenesis and Treatment
- (2018) Rami Z. Morsi et al. CURRENT CANCER DRUG TARGETS
- Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A
- (2018) Alma Abou Samra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phosphorylation alters Bim-mediated Mcl-1 stabilization and priming
- (2018) Jason E. Conage-Pough et al. FEBS Journal
- Coxiella burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1
- (2018) Rama Cherla et al. INFECTION AND IMMUNITY
- miR-596 Modulates Melanoma Growth by Regulating Cell Survival and Death
- (2018) Szu-Mam Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design
- (2018) Subrata Shaw et al. JOURNAL OF MEDICINAL CHEMISTRY
- KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells
- (2018) Zhi-Chuan Zhu et al. ONCOGENE
- Coamplification ofmiR-4728protectsHER2-amplified breast cancers from targeted therapy
- (2018) Konstantinos V. Floros et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MCL-1 is a prognostic indicator and drug target in breast cancer
- (2018) Kirsteen J. Campbell et al. Cell Death & Disease
- Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
- (2018) Shengzhe Zhang et al. Nature Communications
- Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
- (2018) Donia M. Moujalled et al. LEUKEMIA
- A Novel MCL-1 Inhibitor Combined with Venetoclax Rescues Venetoclax Resistant Acute Myelogenous Leukemia
- (2018) Haley E. Ramsey et al. Cancer Discovery
- BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment
- (2018) Patricia Gomez-Bougie et al. BLOOD
- Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer
- (2018) Sonia Vallet et al. BREAST CANCER RESEARCH AND TREATMENT
- Mcl-1 and Bcl-xL are essential for survival of the developing nervous system
- (2018) Lauren C. Fogarty et al. CELL DEATH AND DIFFERENTIATION
- Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode
- (2018) Siham Hedir et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- MCL-1 inhibition in cancer treatment
- (2018) Weiguo Xiang et al. OncoTargets and Therapy
- Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
- (2018) Adriana E. Tron et al. Nature Communications
- Targeting Mcl-1 inhibits survival and self-renewal of hepatocellular cancer stem-like cells
- (2018) Huapeng Zhang et al. Clinics and Research in Hepatology and Gastroenterology
- Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer
- (2017) Jeroen E Guikema et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer
- (2017) Sarah A. Wieczorek et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Toward Understanding Mcl-1 Promiscuous and Specific Binding Mode
- (2017) Jade Fogha et al. Journal of Chemical Information and Modeling
- Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy
- (2017) Guo Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression
- (2017) M Abraham et al. LEUKEMIA
- Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
- (2017) V Shah et al. LEUKEMIA
- Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
- (2017) Delphine Merino et al. Science Translational Medicine
- Mcl-1 inhibitor suppresses tumor growth of esophageal squamous cell carcinoma in a mouse model
- (2017) Jianqing Lin et al. Oncotarget
- Targeting the apoptotic Mcl-1-PUMA interface with a dual-acting compound
- (2017) Jiyuan Liu et al. Oncotarget
- Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors
- (2016) Ziqian Wang et al. ARCHIV DER PHARMAZIE
- Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1
- (2016) J.-N. Gong et al. BLOOD
- Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin–MLL interaction
- (2016) Hai-Jing Zhong et al. CHEMICAL COMMUNICATIONS
- Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma
- (2016) Christopher M Knapp et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors
- (2016) Taekyu Lee et al. FEBS LETTERS
- BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer
- (2016) SHUTARO HABATA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods
- (2016) Nicholas F. Pelz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death
- (2016) Giampaolo Morciano et al. MOLECULAR BIOLOGY OF THE CELL
- Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer
- (2016) Hisato Kawakami et al. MOLECULAR CANCER THERAPEUTICS
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
- (2016) Gizem Akçay et al. Nature Chemical Biology
- FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
- (2016) J Tong et al. ONCOGENE
- Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis
- (2016) Stephanie Grabow et al. Cell Reports
- Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
- (2015) C. Hsu et al. CLINICAL CANCER RESEARCH
- First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-xL-Targeting Strategies
- (2015) Céline Gloaguen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design
- (2015) Jason P. Burke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity
- (2015) Milan Bruncko et al. JOURNAL OF MEDICINAL CHEMISTRY
- MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
- (2015) Y. Xiao et al. MOLECULAR CANCER THERAPEUTICS
- Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
- (2015) J D Leverson et al. Cell Death & Disease
- Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
- (2015) D C Phillips et al. Blood Cancer Journal
- Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells
- (2014) Glenna Wink Foight et al. ACS Chemical Biology
- IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells
- (2014) Aparna R. Shenoy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Carboxyl-terminal Tail of Noxa Protein Regulates the Stability of Noxa and Mcl-1
- (2014) Xiaming Pang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Protein Phosphatase 2A (PP2A) Prevents Mcl-1 Protein Dephosphorylation at the Thr-163/Ser-159 Phosphodegron, Dramatically Reducing Expression in Mcl-1-amplified Lymphoma Cells
- (2014) Shanna K. Nifoussi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Many players in BCL-2 family affairs
- (2014) Tudor Moldoveanu et al. TRENDS IN BIOCHEMICAL SCIENCES
- Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer
- (2014) W Nakajima et al. Cell Death & Disease
- Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker
- (2013) David J. Richard et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia
- (2013) B. Koss et al. BLOOD
- Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma
- (2013) Christopher S. McKee et al. EXPERIMENTAL DERMATOLOGY
- Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
- (2013) X. Wang et al. GENES & DEVELOPMENT
- A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
- (2013) F. Abulwerdi et al. MOLECULAR CANCER THERAPEUTICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
- (2013) Jie Gao et al. PLoS One
- MCL-1ES Induces MCL-1L-Dependent BAX- and BAK-Independent Mitochondrial Apoptosis
- (2013) Jae-Hong Kim et al. PLoS One
- Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
- (2013) R. Pan et al. Cancer Discovery
- A Competitive Stapled Peptide Screen Identifies a Selective Small Molecule that Overcomes MCL-1-Dependent Leukemia Cell Survival
- (2012) Nicole A. Cohen et al. CHEMISTRY & BIOLOGY
- Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors
- (2012) G. J. Gores et al. GENES & DEVELOPMENT
- Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation
- (2012) Kenichiro Doi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
- (2012) Anders Friberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma
- (2012) S-S Wenzel et al. LEUKEMIA
- Notch-Induced hIL-6 Production Facilitates the Maintenance of Self-Renewal of hCD34+ Cord Blood Cells Through the Activation of Jak-PI3K-STAT3 Pathway
- (2011) Bongkum Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Pharmacological Properties of the Marine Natural Product Marinopyrrole A against Methicillin-Resistant Staphylococcus aureus
- (2011) Nina M. Haste et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Targeting Mcl-1 for the therapy of cancer
- (2011) Bridget A Quinn et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Anti-cancer natural products isolated from chinese medicinal herbs
- (2011) Wen Tan et al. Chinese Medicine
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia
- (2010) Zhifu Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Cryptosphaerolide, a Cytotoxic Mcl-1 Inhibitor from a Marine-Derived Ascomycete Related to the GenusCryptosphaeria
- (2010) Hyuncheol Oh et al. JOURNAL OF NATURAL PRODUCTS
- The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
- (2010) Michelle L Stewart et al. Nature Chemical Biology
- MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death
- (2009) Jae-Hong Kim et al. FEBS LETTERS
- A Dimeric Sesquiterpenoid from a MalaysianMeiogyneas a New Inhibitor of Bcl-xL/BakBH3 Domain Peptide Interaction⊥
- (2009) Marc Litaudon et al. JOURNAL OF NATURAL PRODUCTS
- Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia
- (2009) Lauren Véronèse et al. LEUKEMIA RESEARCH
- Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
- (2009) K. Boisvert-Adamo et al. MOLECULAR CANCER RESEARCH
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now